糖皮质激素支架植入联合鼻内镜手术对慢性鼻窦炎伴鼻息肉患者鼻腔通气功能及鼻黏膜恢复的影响

Effects of glucocorticoid stent implantation combined with nasal endoscopic surgery on nasal ventilation function and nasal mucosa recovery in patients with chronic sinusitis with nasal polyps

摘要:

目的 分析糖皮质激素支架植入联合鼻内镜手术对慢性鼻窦炎伴鼻息肉（CSwNP）患者鼻腔通气功能及血清嗜酸粒细胞阳离子蛋白（ECP）、纤维连接蛋白（Fn）和水通道蛋白-1（AQP-1）水平的影响。方法 选择2022年1月－2023年2月该院收治的CSwNP患者60例，采用随机数表法分为试验组和对照组，各30例。试验组在原有鼻内镜手术基础上联用糖皮质激素支架植入治疗，对照组接受鼻内镜手术治疗，两组患者随访至术后12周。比较两组患者鼻部症状、生活质量、鼻腔结构、通气功能、血清ECP、Fn、AQP-1水平和不良反应发生情况。结果 与治疗前比较，治疗后12周两组患者鼻腔黏膜结构评分（Lund-Mackay评分）、鼻部症状视觉模拟评分法（VAS）（包括：鼻塞、流涕、头部闷胀感、嗅觉减退、鼻腔干燥/结痂感）和血清ECP水平降低，鼻腔最小横截面至前鼻孔距离（DCAN）缩短，且试验组低于对照组，差异均有统计学意义（P < 0.05）。与治疗前比较，治疗后12周，两组患者鼻腔最小横截面积（NMCA）和鼻腔容积（NCV）增大，世界卫生组织生活质量测定量表简表（WHOQOL-100量表）评分、血清Fn和AQP-1水平升高，且试验组高于对照组（P < 0.05）。治疗期间，两组患者不良反应发生率比较，差异无统计学意义（P > 0.05）。结论 糖皮质激素支架植入联合鼻内镜手术可缓解CSwNP患者鼻部症状，改善鼻腔结构和通气功能，调节血清ECP、Fn和AQP-1水平，提高患者生活质量。

Abstract:

Objective To analyze the effects of glucocorticoid stent implantation combined with nasal endoscopic surgery on nasal ventilation function and serum levels of eosinophil cationic protein (ECP), fibronectin (Fn) and aquaporin-1 (AQP-1) in patients with chronic sinusitis with nasal polyp (CSwNP).Methods 60 patients with CSwNP from January 2022 to February 2023 were included in the study, and then they were divided into experimental group and control group, with 30 cases in each, using random number table method. The experimental group was treated with glucocorticoid stent implantation based on the original nasal endoscopic surgery, and the control group was treated with nasal endoscopic surgery, and both groups were treated until 12 weeks after surgery. The two groups of nasal symptoms, quality of life, nasal structure and ventilation function, serum levels of ECP, Fn, AQP-1, and adverse reactions were compared.Results Compared before the treatment, scores of nasal mucosal structure (Lund-Mackay scale), nasal symptom visual analogue scale (VAS) (including: nasal obstruction, runny nose, stuffy head, decreased sense of smell, nasal dryness/scab) and serum levels of ECP were decreased, distance from minimum nasal cross section to anterior nostril (DCAN) was shortened in two groups 12 weeks after treatment, and the experimental group was lower than the control group, the differences were statistically significant (P < 0.05). Compared before the treatment, 12 weeks after treatment, the nasal minimum cross-sectional area (NMCA), score of world health organization abbreviated quality of life (WHOQOL-100), nasal cavity volume (NCV), serum levels of Fn, AQP-1 were increased in two groups, and the experimental group was higher than the control group, the differences were statistically significant (P < 0.05). During treatment, the incidence of adverse reactions was similar between the two groups (P > 0.05).Conclusion Glucocorticoid stent implantation combined with nasal endoscopic surgery can control nasal symptoms in patients with CSwNP, improve nasal structure and ventilation function, regulate serum levels of ECP, Fn, AQP-1, and improve patients' quality of life.